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Abstract
Background: The Asthma Control Test (ACT) is widely used to assess asthma control, yet the validity and reliability
of the test have not been specifically evaluated in adolescents or African-Americans. We conducted a prospective
psychometric study of the ACT in African-American (AA) and non-African-American (nAA) adolescents with
persistent asthma, with emphasis on the clinical utility of the test for medical decision making.
Methods: Participants completed the ACT and performed spirometry. A physician conducted a guidelines-based
assessment of asthma control, blinded to the ACT score. Study procedures were repeated 6–8 weeks later. The
ACT-based asthma control assessment was compared to physician assessment.
Results: For baseline and follow-up visits, internal consistency, as measured using Cronbach’s alpha, was 0.80 and
0.81 in AA teens and 0.80 and 0.83 in nAA teens. Intraclass correlation coefficients were 0.59 and 0.76 in AA and
nAA teens, respectively, with stable asthma control over time. Agreement between ACT and physician assessment
was moderate in AA teens and fair in nAA teens. An ACT score of ≤19 showed reduced sensitivity for not well
controlled asthma in both groups, while a score of ≤21 had the greatest area under the ROC curve. ACT scores
were marginally responsive to change in control status.
Conclusions: Concerns for the ACT’s ability to detect uncontrolled asthma in adolescents emphasizes the need for
a more comprehensive evaluation of asthma control in clinical settings. A higher threshold ACT score to define not
well controlled asthma may be needed if the ACT is to be used for medical decision making.
Trial registration: ClinicalTrials.gov: NCT02671643, NCT02662413.
Keywords: Asthma, The asthma control test (ACT), African-American, Adolescent, Questionnaire, Control, Validity,
Reliability
Background
Asthma is a common chronic illness with significant
morbidity and mortality, despite the availability of
evidence-based treatment guidelines. There continues
to be noticeable disparity in asthma outcomes among
African-Americans, with rates of asthma-related healthcare
utilization and death approximately 2 to 3 times the rates
seen in Caucasians [1]. Asthma among African-Americans
is disproportionally not well controlled [2–4]. Adolescence
may add additional risk, as children are becoming more
independent from their parents and engaging in risk-tak-
ing behaviors [5]. Teenagers with uncontrolled asthma
are more likely to “normalize” their asthma and have
a higher threshold for reporting symptoms and initiat-
ing treatment [6].
The National Asthma Education and Prevention Pro-
gram (NAEPP) guidelines recommend assessment of
asthma control at each asthma visit, including frequency
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of asthma symptoms and rescue medication use, activity
limitation, unscheduled healthcare visits, and spirometry
measurement [7], and have incorporated use of stan-
dardized asthma questionnaires including the Asthma
Control Test (ACT)™ into this assessment. Asthma ques-
tionnaires have taken a leading role in clinical manage-
ment and are also frequently used in research for subject
selection and for measurement of treatment effects. The
self-administered questionnaire assessing impairment
during the previous four weeks was validated for use in
those 12 years and older [8], but concerns have been
raised about the performance of the ACT in adolescents
and ethnic minority populations [9], who were
under-represented in previous validation studies. While
a score of 19 or less out of a possible 25 points showed
the greatest sensitivity and specificity for uncontrolled
asthma [8], these findings were derived from predomin-
antly Caucasian adult study populations, with median
ages of 35 to 45 years [8, 10]. Studies examining the use
of the ACT in adolescents of European and Mexican an-
cestry have reported higher optimal cut points to distin-
guish well controlled from uncontrolled asthma [11–13].
This divergence may be in part due to cultural and de-
velopmental or age-related differences in the way symp-
toms are perceived and reported, as well as differences
in health literacy when compared to Caucasian adults.
While questionnaires like the ACT were initially devel-
oped to serve as one component of the asthma control
assessment, many busy practices have embraced the
ACT as essentially a replacement for the recommended
multidimensional assessment. This is especially concern-
ing given the questions surrounding the performance of
the ACT in teens and minorities who may already be
more likely to have their asthma severity underestimated
by healthcare providers [14–17]. To avoid inappropriate
medical management, it is imperative that tools like the
ACT, which rely solely on patient-reported data, be vali-
dated in the populations in which they are frequently
used [18].
To address these questions, we conducted a prospect-
ive study to evaluate the validity and reliability of the
ACT in African-American and non-African-American
adolescents with persistent asthma, with emphasis on
the clinical utility of the ACT for asthma management.
Methods
Subjects/recruitment
Participants were recruited from the University of North
Carolina’s pediatric allergy and pulmonology subspecialty
clinics and general pediatric clinics. We enrolled adoles-
cents ages 12 to 18 years with a physician diagnosis of
persistent asthma who were using a controller medication
(inhaled corticosteroid, combination inhaled corticoster-
oid/long acting beta agonist, or leukotriene receptor
antagonist). Children were included in the African-Ameri-
can (AA) or non-African-American (nAA) cohorts based
on their self-identification of racial/ethnic background.
Children were excluded from study if they had a diagnosis
of pulmonary disease other than asthma (such as vocal
cord dysfunction or cystic fibrosis), if they were unable to
perform spirometry, or if they were unable to speak and
read English. Written informed consent and assent were
obtained from participating children and their guardians
(if the participant was less than 18 years of age).
Study protocol
Each participant presented for two study visits. At the
baseline visit, teens completed the ACT questionnaire
without the help of the parent/guardian. The coordin-
ator obtained past medical history, reviewed home medi-
cations, allergies, review of systems, and performed
spirometry. Atopy was defined by a documented history
of sensitization to 1 or more aeroallergens (by skin prick
testing or serum IgE testing), history of allergic rhinitis,
food allergy, or atopic dermatitis. A study physician,
blinded to the ACT score, then obtained a standardized
asthma history assessing the frequency of asthma symp-
toms and rescue medication use, activity limitation, and
asthma-related healthcare utilization over the prior
4 weeks (see Additional file 1: Table S1 in the Online Re-
pository) in addition to a focused physical exam. Taking
into account history, patient-reported symptoms (other
than the ACT), physical exam findings, and spirometry
measurements, the study physician made an assessment
of asthma control as being either well controlled or not
well controlled. Participants returned six to eight weeks
later for their follow up study visit, and the same proce-
dures were repeated. The study protocol was approved
by the University of North Carolina’s institutional re-
view board.
ACT measurements
Reliability
To estimate internal consistency reliability, or the
consistency among responses to items in the ACT at a
single assessment point, Cronbach’s coefficient alpha
was computed for baseline and follow-up visits for AA
and nAA teens. A value of 0.70 or greater is considered
an acceptable reliability estimate for group-level assess-
ment of asthma control (such as in a clinical trial), and a
threshold of 0.90 or greater is recommended for
individual-level assessments as would be made for rou-
tine clinical care and screening [19–21]. Intraclass cor-
relation coefficients (ICC) were calculated to estimate
test-retest reliability, or the degree to which ACT scores
are similar over time when there is no change in the par-
ticipants’ asthma control. An ICC of less than 0.5 is as-
sociated with poor reliability, 0.5–0.75 is fair, 0.75–0.9 is
Burbank et al. Respiratory Research  (2018) 19:152 Page 2 of 9
good, and greater than 0.9 is associated with excellent
reliability [22].
Criterion and construct validity
We evaluated criterion validity by computing Cohen
kappa (κ) statistics, which measure the agreement be-
tween asthma control assessments (ACT vs physician
assessment) [23, 24]. κvalues ≤0 indicate no agreement,
0.01–0.2 slight agreement, 0.21–0.4 fair agreement, 0.41–
0.6 moderate agreement, 0.61–0.8 substantial agreement,
and 0.81–1.0 almost perfect agreement. Pearson correl-
ation coefficients were calculated between baseline ACT
scores and spirometry measurements. Construct validity
(specifically, known groups validity) was measured by
comparing 1) mean ACT scores of teens with well con-
trolled asthma to those with not well controlled asthma
using Student’s t test, and 2) mean ACT scores between
groups differing by severity of airway obstruction
(measured by spirometry) by ANOVA.
Screening accuracy
We determined the accuracy of the ACT for detecting not
well controlled asthma in AA and nAA teens using re-
ceiver operating characteristic (ROC) analyses. Physician
assessment of asthma was used as the “gold standard”.
Sensitivity, specificity, positive and negative predictive
values, and areas under the ROC curve were calculated
for cut point scores from ≤10 to ≤24.
Responsiveness
Responsiveness of the ACT to change in asthma control
status was determined by calculating Pearson correlation
coefficients for the relationship between change in ACT
score and 1) change in physician assessment of asthma
control and 2) change in spirometry measurements. Mean
change in ACT scores was compared between groups
whose physician-assessed asthma control improved,
remained stable, or worsened using ANOVA.
Results
Participants
Fifty-four AA teens and 36 nAA teens with persistent
asthma participated in the study. Fifty-two AA teens and
35 nAA teens completed both study visits. One AA teen
and 3 nAA teens were receiving step 1 therapy despite a
diagnosis of persistent asthma and were excluded from
the analysis. The AA and nAA groups were similar in
terms of age, sex distribution, BMI, % predicted FEV1,
and presence of atopy (Table 1). Asthma severity for the
two groups was approximated by treatment step, with
Table 1 Subject Demographics
AA
(N = 53)
nAA
(N = 33)
Age in years, median (range) 13.8 (12–18) 13.5 (12–18)
Sex – Feale, n(%) 26 (50%) 14 (42%)
Race/Ethnicity to which subject self-identifies 53 African-American 25 Caucasian
2 Asian
5 Hispanic/Latino
1 Native American
BMI %tile for age/sex, median (range) 72 (3–99) 72 (1–99)
% predicted FEV1, median (range) 93 (50–138) 92 (54–114)
% predicted FEV1, n (%)
< 60% 1 (2) 1 (3)
60–79% 8 (15) 2 (6)
80–100% 26 (49) 23 (70)
> 100% 18 (34) 7 (21)
NAEPP Treatment Step, n (%) Step 2–6 (11) Step 2–7 (21)
Step 3–11 (21) Step 3–10 (30)
Step 4–8 (15) Step 4–7 (21)
Step 5–26 (49) Step 5–7 (21)
Step 6–0 (0) Step 6–1 (3)
Unknown – 2 (4) Unknown – 1 (3)
Asthma Control, n (%) Well controlled – 21 (40) Well controlled – 19 (58)
Not well controlled – 32 (60) Not well controlled - 14 (42)
History of atopic disease, N (%) 49 (92) 30 (91)
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85% of the AA group and 76% of the nAA group requiring
Step 3 therapy or higher, indicating at least moderate per-
sistent asthma in the majority of participants [7]. Eight
AA and 5 nAA participants were receiving anti-IgE mono-
clonal antibody therapy during the study period. At the
baseline visit, 60% of AA teens and 42% of nAA teens had
asthma that was not well controlled.
Reliability
Cronbach’s coefficient alpha was computed for both the
AA and nAA groups at baseline and follow-up visits.
Cronbach’s alpha of the ACT was 0.80 and 0.81 for the
AA teens at baseline and follow-up visits, respectively.
For the nAA teens, Cronbach’s alpha was calculated at
0.80 and 0.83 for baseline and follow up visits, respect-
ively. Among those with stable asthma control during
the study, ICC was 0.59 in the AA group (37 observa-
tions) and 0.76 in the nAA group (19 observations).
Criterion and construct validity
The previously established cut point of ≤19 was associ-
ated with a κof 0.43 in the AA group and 0.36 in the
nAA group, consistent with moderate and fair agree-
ment between physician and ACT assessment of asthma
control, respectively [23, 24]. These findings are compar-
able to a recent systematic review and meta-analysis of
studies examining the performance of the ACT [25]. To
test construct validity, we compared the mean ACT scores
for those with well controlled asthma to those with not
well controlled asthma and found that in both AA and
nAA teens, those with not well controlled asthma had sta-
tistically significantly lower ACT scores than those with
well controlled asthma (Table 2). For the AA group at
baseline, mean ACT score difference was 4.13 (well con-
trolled – not well controlled) (p < 0.0001). Similarly for
the nAA group, the mean ACT score difference was 4.58
points (p = 0.0002). Baseline visit ACT scores were poorly
correlated with baseline spirometry measurements in both
AA and nAA teens (see Additional file 1: Table S2 in the
Online Repository).
Screening accuracy
In AA teens, the currently recommended cut point score
of ≤19 to indicate not well controlled asthma showed re-
duced sensitivity (56%) and NPV (58%) compared to pre-
vious studies (Table 3) [8, 10]. A score of ≤21 achieved the
greatest area under the ROC curve at 0.76 with sensitivity
and PPV of 81% and specificity and NPV of 71% (Fig. 1).
Table 2 Discriminant validity of the ACT at the first study visit in AA and nAA adolescents
African-Americans Non-African-Americans
Physician Assessment of Asthma
n Mean (SD)
ACT Score
p n Mean (SD)
ACT Score
p
Controlled 21 22.4 (2.2) < 0.0001 19 22.8 (2.4) 0.0003
Not well controlled 32 18.3 (3.7) 14 18.2 (4.1)
Spirometry
n Mean (SD)
ACT Score
F p n Mean (SD) ACT Score F p
% predicted FEV1
< 60% 1 24 (0) 0.5 0.68 1 13 (0) 1.51 0.23
60–79% 8 19.25 (2.32) 2 21.5 (0.71)
80–100% 26 19.73 (3.92) 23 21.17 (4.05)
> 100% 18 20.17 (4.20) 7 20.43 (3.16)
FEV1/FVC
< 60% 0 – – 0.32† 1 13 (0) 2.83 0.07
60–79% 25 19.72 (3.04) 11 20.09 (4.53)
80–100% 28 20.04 (4.39) 21 21.52 (3.20)
> 100% 0 – 0 –
FEF25–75
< 60% 21 19.62 (3.12) 0.88 0.46 5 18.2 (3.96) 0.89 0.46
60–79% 12 21.33 (2.64) 12 21 (4.41)
80–100% 9 18.78 (5.17) 10 21.3 (3.37)
> 100% 11 19.73 (4.69) 6 21.67 (3.67)
†Mann-Whitney U test
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Increasing the cut point to ≤21 improved the level of
agreement between ACT and physician assessment, or κ,
from 0.43 to 0.53. Similar to AA teens, for nAA teens a
cut point score of ≤21 provided the maximum area under
the ROC curve at 0.79 with sensitivity and specificity of
79%, PPV of 73%, and NPV of 83% (Table 4). Using ≤21 as
the cut point increased κfrom 0.36 to 0.57.
Additionally, we conducted an analysis of baseline visit
responses to each of the five ACT questions to deter-
mine if particular questions were more or less predictive
of not well controlled asthma (see Additional file 1: Ta-
bles S3 and S4 in the Online Repository). Within the AA
group, we found that question 1 (“In the past 4 weeks,
how much of the time did your asthma keep you from
getting as much done at work, school or at home?”) and
question 3 (“During the past 4 weeks, how often did your
asthma symptoms (wheezing, coughing, shortness of
breath, chest tightness or pain) wake you up at night or
earlier than usual in the morning?”) had the best
screening properties for not well controlled asthma. We
then examined the screening properties of every possible
pair of ACT questions and again found that questions 1
and 3 produced the best results. At the baseline visit, a
score of ≤9 for this “sub-test” amongst AA teens was
91% sensitive and 86% specific for not well controlled
asthma, with an area under the ROC curve of 0.88.
These findings were not replicated at the follow up visit
for AA teens nor were similar results found at either
visit for nAA teens.
Responsiveness to change
To determine the responsiveness of the ACT question-
naire to changes in asthma control status over time, we
calculated the correlation between change in ACT score
and change in physician assessment of control between
baseline and follow up study visits. Few participants ex-
perienced a change in asthma control status during the
study period. A small but statistically significant correl-
ation was seen between change in ACT score and
change in asthma control in AA teens (r = 0.29, p = 0.04)
but not in nAA teens (r = 0.32, p = 0.08). Within the
nAA group only, we identified a significant difference in
mean change in ACT score between participants whose
asthma improved, worsened, or stayed the same (F = 3.2,
p = 0.05) (Table 5). Change in ACT score was
significantly correlated with change in FEV1 (r = 0.53,
p = 0.002) and FEV1/FVC (r = 0.55, p = 0.001) in nAA
teens but not in AA teens (ΔFEV1, r = 0.11, p = 0.46 and
ΔFEV1/FVC, r = 0.2, p = 0.15) (see Additional file 1:
Table S5 in the Online Repository).
Discussion
Standardized patient-reported questionnaires like the
ACT allow providers to quickly assess asthma control in
busy clinical practices. While previous studies have pro-
vided evidence in support of the validity and reliability
Table 3 Screening accuracy of the ACT for not well controlled
asthma in African-American teens
ACT score κ Sensitivity Specificity PPV NPV AUC
≤14 0.128 0.156 1.000 1.000 0.438 0.578
≤15 0.182 0.219 1.000 1.000 0.457 0.609
≤16 0.237 0.281 1.000 1.000 0.477 0.641
≤17 0.254 0.344 0.952 0.917 0.488 0.648
≤18 0.303 0.438 0.905 0.875 0.514 0.671
≤19 0.425 0.562 0.905 0.900 0.576 0.734
≤20 0.482 0.656 0.857 0.875 0.621 0.757
≤21 0.527 0.812 0.714 0.812 0.714 0.763
≤22 0.494 0.938 0.524 0.750 0.846 0.731
≤23 0.338 0.969 0.333 0.689 0.875 0.651
≤24 0.221 1.000 0.190 0.653 1.000 0.595
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Fig. 1 Receiver operating characteristic (ROC) curves generated from
ACT scores from the first study visit for AA and nAA teens indicate a
score of ≤21 achieved the optimal balance of sensitivity and specificity
for detection of not well controlled asthma and the largest area under
the ROC curve
Table 4 Screening accuracy of the ACT for not well controlled
asthma in non-African-American teens
ACT score κ Sensitivity Specificity PPV NPV AUC
≤14 0.161 0.143 1.000 1.000 0.613 0.571
≤15 0.315 0.286 1.000 1.000 0.655 0.643
≤16 0.390 0.357 1.000 1.000 0.679 0.679
≤17 0.329 0.357 0.947 0.833 0.667 0.652
≤18 0.402 0.429 0.947 0.857 0.692 0.688
≤19 0.355 0.500 0.842 0.700 0.696 0.671
≤20 0.494 0.643 0.842 0.750 0.762 0.742
≤21 0.570 0.786 0.789 0.733 0.833 0.788
≤22 0.530 0.929 0.632 0.650 0.923 0.780
≤23 0.371 0.929 0.474 0.565 0.900 0.701
≤24 0.281 1.000 0.316 0.519 1.000 0.658
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of the ACT for detecting suboptimal asthma control
[8, 10, 25], information on how the test performs in ado-
lescents and in ethnically diverse populations is lacking
given concerns that the questionnaire may not be sensitive
to how teenagers and minorities perceive asthma-related
impairment. Because minorities and teens/young adults
are already at higher risk of poor asthma outcomes, it is
imperative to understand the value of the tools being used
to drive management decisions in these groups, to avoid
overestimating level of control and under-treating asthma.
Our results suggest that the currently accepted ACT
cut point score of ≤19 showed reduced accuracy com-
pared to previous studies [8, 10, 25] in identifying
asthma that is not well controlled in both AA and nAA
adolescents. In both groups, use of a higher cut point
score of ≤21 achieved the greatest area under the ROC
curve and the best balance of sensitivity and specificity
for identification of not well controlled asthma. That
these results were seen in both AA and nAA groups sug-
gests that a higher ACT cut point score may be neces-
sary in adolescents. It is well established that children
and adolescents are less accurate in describing their per-
ceived asthma control [26–32], impacted by age and de-
velopmental level. They may “normalize” their asthma
symptoms and therefore not recognize them as being
problematic, or they may minimize symptoms to avoid
being categorized as different from their peers [33, 34].
Given these well documented differences in symptom
perception and reporting, it seems logical to adjust the
expectations of self-administered questionnaires that are
based primarily on patient-reported data points. It is also
important to emphasize that this is not a problem iso-
lated to teenagers. In fact, using the childhood ACT
(cACT) for children under 12 years, our group has pub-
lished evidence that caregiver perception of asthma con-
trol may be even more discrepent from physician
assessment than teen perception [9].
Analysis of individual ACT questions demonstrates that
certain elements of the assessment may be more predict-
ive of uncontrolled asthma than others in AA teens, par-
ticularly activity limitation and nighttime symptoms. This
subtest requires further study to determine its potential
utility as an adjunct measure of asthma control but em-
phasizes the importance of considering cultural context in
the design of standardized questionnaires. For example,
African-Americans with asthma may report less nighttime
awakening and dyspnea, two symptoms that account for
20% of the ACT score [15, 26, 35]. This leads to
under-reporting of symptoms, which reflects a false level
of asthma control when queried by the ACT.
Our findings demonstrate acceptable levels of internal
consistency reliability for both the AA and nAA teens at
the group level; however, the reliability is below what is
the recommended threshold for individual level assess-
ment. This finding recognizes that there is a higher level
of measurement error associated with the estimate that
may caution providers to not solely rely on the ACT for
determining asthma control. Further, the test-retest reli-
ability of the ACT within the AA teen group was lower
than the nAA teens. There should be some caution in
overinterpreting the test-retest reliability as there was a
6–8 week time lapse between the baseline and follow up
assessments; thus, patients’ stable asthma control status
could fluctuate and participants’ memory of their control
at baseline may be less clear.
Few participants experienced a change in level of
asthma control, which was not surprising given the lack
of an intervention and the brief 6–8 week study period.
The responsiveness of the ACT to changes in asthma
control was marginal in both AA and nAA adolescents.
We found no significant correlation between change in
ACT scores and change in asthma control status among
nAA teens, with a small yet statistically significant cor-
relation in AA teens. However, we found no difference
in mean change in ACT scores between groups whose
asthma worsened, improved, or remained stable in the
AA group, suggesting that ACT scores do not signifi-
cantly increase or decrease with improved or worsened
asthma control, respectively. Interestingly, change in
ACT score was strongly correlated with change in FEV1
and FEV1/FVC in nAA teens but very poorly correlated
in AA teens, despite similar median % predicted FEV1
between the two groups.
The ACT did not discriminate well between participants
with higher lung function and those with lower lung func-
tion, as seen in previous studies [8, 10, 36]. However, we
recognize that in children especially, spirometry alone is
often a poor measure of asthma control, since children
often have normal spirometry despite poorly controlled
asthma. Indeed in our study, the median %predicted FEV1
Table 5 Responsiveness of the ACT to change in physician-assessed asthma control
African-American Non-African-American
Physician Assessment Mean (SD) change
in ACT score
F p Physician Assessment Mean (SD) change in ACT score F p
Worsened control (n = 4) −1.00 (3.56) 2.19 0.12 Worsened control (n = 5) 0.4 (2.07) 3.23 0.05
Unchanged (n = 37) 0.49 (3.66) Unchanged (n = 19) −0.32 (2.75)
Improved control (n = 10) 2.80 (3.33) Improved control (n = 8) 3.38 (5.26)
Burbank et al. Respiratory Research  (2018) 19:152 Page 6 of 9
for both AA and nAA teens was greater than 90%, despite
a significant proportion of our subjects having asthma that
was not well controlled.
The fair to moderate agreement (κ) between the ACT
and NAEPP-based physician assessment of asthma con-
trol is consistent with prior validation studies but, in our
view, emphasizes the danger of relying too heavily on
the ACT score for medical decision making. We argue
that while the ACT using an optimized threshold score
may be a useful screening tool, it should not replace a
comprehensive physician assessment of control in the
clinical setting. However, the context in which the ques-
tionnaire is being used may impact its utility and the
choice of cut point score. For example, when used in the
clinical setting, a more sensitive cut point should be
chosen to minimize false negatives (persons with asthma
that is not well controlled whose ACT score indicates
controlled disease). Conversely in the research setting if
the goal is to recruit poorly controlled asthmatics, a cut
point that maximizes specificity, reducing the rate of
false positives, is desired to avoid recruiting well con-
trolled asthmatics to the study.
Accurate assessment of asthma control requires evalu-
ation of both of the essential elements that comprise
control: impairment and risk of future exacerbations.
Pediatric asthma is often associated with low levels of
day-to-day impairment but excessive risk in the form of
frequent exacerbations, often occurring with viral re-
spiratory infections. The ACT primarily measures im-
pairment and does not take into account elements that
increase risk (such as history of exacerbations in the
prior year, unscheduled healthcare visits or hospitaliza-
tions for asthma), which may limit its utility in pediatric
patients. The ACT also provides no mechanism to esti-
mate asthma severity. The Composite Asthma Severity
Index (CASI) takes into account impairment, exacerba-
tions, controller medication requirement and lung func-
tion to provide a more comprehensive evaluation of
asthma and to measure response to therapies [37]. A
similar multipronged evaluation of asthma may be a bet-
ter guide for stepping up or down treatment in clinical
practice or for measuring asthma treatment responses in
clinical research.
Our study has several limitations. The relatively small
sample size increased the variance seen and did not allow
us to explore sub-group differences by age (e.g., 12–15 years
vs 16–18 years) to examine whether younger children had
more challenges than older children in understanding the
questionnaire or relating their asthma control experiences
to answer the questions. All participants and their care-
givers were required to speak English to participate in the
study, which hindered recruitment of Latino children, an-
other group at high risk of asthma-related morbidity. Our
physician assessment of asthma control was binary (well
controlled vs not well controlled) in contrast to other stud-
ies that incorporated terms such as “partly controlled”,
“somewhat controlled”, or “not at all controlled,” which
may have limited our ability to assess the discriminant val-
idity of the test. Few participants had a change in their
asthma control status between the two study visits, which
likely limits our ability to make inferences about respon-
siveness of the ACT to change. While the AA and nAA
teen groups were well matched in terms of age, sex, atopic
status, BMI, and FEV1, the AA group contained a larger
proportion of participants on step 5 therapy or above com-
pared to the nAA (49% vs 24%), suggesting increased
asthma severity within the AA group. To address the possi-
bility that our study populations may have contained a
higher number of “poor perceivers” of asthma symptoms
relative to the general adolescent population, we recruited
from both general pediatrics clinics and subspecialty clinics
in an effort to achieve more generalizable results. However,
replication of this study in a larger group with a wider
range of disease severity is needed before these findings can
be applied to asthmatic teenagers in general.
Conclusions
We found some evidence for the validity of the ACT but
not ideal levels of reliability for individual level assessment
along with reduced sensitivity for detection of not well
controlled asthma in adolescents with persistent asthma,
independent of race. A higher threshold value to define
asthma control improved the predictive properties of the
ACT and requires further investigation. Additionally, AA
teens’ scores were less responsive to change than nAA
teens, suggesting that use of the ACT to detect changes in
clinical status over time may be impaired in this popula-
tion. While the ACT should be used to support the assess-
ment of asthma control, it should not be relied upon as
the sole indicator of control and should not replace the
NAEPP-guidelines based physician assessment.
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